Biofluorescent particle counters (BFPCs) offer a way to strengthen EM programs by filling critical gaps in timing, coverage, and responsiveness. BFPCs add real-time insight and elevate contamination control strategies. As the industry continues to move toward continuous monitoring and more data-driven decision-making, BFPCs are positioned to play a central role in the future of EM.

MicronView at the 2025 ISPE Biotechnology Conference – the premier global event uniting pharmaceutical and biopharmaceutical innovators, technology pioneers, academic leaders, and regulatory experts.

As pharmaceutical manufacturers seek to modernize and de-risk their aseptic processing workflows, Biofluorescent Particle Counters (BFPCs), such as MicronView’s BAMS, are emerging as a critical tool for continuous viable particle monitoring. These real-time systems, which detect biologic particles using laser-induced fluorescence, offer immediate contamination insight—dramatically reducing the time to result compared to traditional culture-based methods.

From March 25–27, 2025, the Lounges Cleanroom Processes exhibition was held at Messe Karlsruhe, Germany. PMT, in collaboration with MicronView, presented its leading intelligent cleanroom solutions, drawing significant attention from industry professionals.